Riskpilot← Back to searchSign inGet full accessBIO-INFORMATION TECHNOLOGY AS
ASActiveOrg 936864643Måkeveien 1B, 3112 TønsbergEngineering activities and related technical consultancy · NACE 7112Est. 19850 employees
Revenue 2024
NOK 0
EBITDA margin
—
-2070% vs 2023
Equity ratio
-42.7%
Financial strength
Net profit 2024
NOK -2,5M
-153% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -897K | -2070% |
| Net profit | NOK -2,5M | -153% |
| Total assets | NOK 12,6M | +5% |
| Equity | NOK -5,4M | -24% |
| Employees | 0 | — |
Legal name
BIO-INFORMATION TECHNOLOGY AS
Org number
936864643
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
2. januar 1985
Share capital
—
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Forretningsmessig utnyttelse av selskapets kompetanse på området biologisk informasjonsteknologi, samt forskning og utvikling, andel og aksjekjøp i andre virksomheter, generell handelsvirksomhet, investeringer i inn- og utland, og alt som for øvrig kan forbindes med dette.
Address
Måkeveien 1B, 3112 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 2 500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −27 | −338 | −67 | 2 265 | −30 | −28 | −36 | −29 | −19 | −25 | −29 | −16 | −36 | −33 | −50 | −41 | −897 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −27 | −338 | −67 | 2 265 | −30 | −28 | −36 | −29 | −19 | −25 | −29 | −16 | −36 | −33 | −50 | −41 | −897 |
| Net financials | −600 | 6 375 | 2 425 | −2 270 | −5 052 | −759 | −669 | −1 035 | −771 | −825 | −898 | −991 | −1 095 | −1 207 | −1 336 | −1 487 | −2 001 |
| Profit before tax | −627 | 6 036 | 2 358 | −5 | −5 082 | −787 | −706 | −1 064 | −791 | −851 | −927 | −1 007 | −1 131 | −1 240 | −1 386 | −1 528 | −2 898 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −6 | −0 | −718 | −0 | −27 | −24 | −11 | −542 | −406 |
| Net profit | −627 | 6 036 | 2 358 | −5 | −5 082 | −787 | −706 | −1 064 | −784 | −851 | −209 | −1 007 | −1 103 | −1 217 | −1 375 | −986 | −2 492 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10 439 | 20 381 | 23 649 | 13 965 | 8 581 | 8 076 | 7 330 | 7 128 | 6 400 | 6 250 | 9 511 | 9 417 | 9 539 | 9 582 | 9 605 | 11 966 | 12 606 |
| Equity | 4 565 | 11 084 | 13 443 | 6 138 | 1 056 | 269 | −437 | −1 501 | −2 266 | −3 117 | −781 | −1 788 | −2 794 | −3 927 | −5 265 | −4 330 | −5 383 |
| Long-term debt | 5 000 | 6 000 | 10 500 | 6 882 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 | 6 349 |
| Short-term debt | 874 | 3 297 | −294 | 945 | 1 176 | 1 458 | 1 418 | 2 280 | 2 317 | 3 017 | 3 943 | 4 856 | 5 984 | 7 161 | 8 521 | 9 947 | 11 640 |
| Total debt | 5 874 | 9 297 | 10 206 | 7 827 | 7 525 | 7 807 | 7 767 | 8 629 | 8 666 | 9 366 | 10 292 | 11 205 | 12 333 | 13 510 | 14 870 | 16 296 | 17 989 |
EBITDA margin
-89650300.0%
This company
15.8%
Market median
-567407062% vs market
20082024
Equity ratio
-42.7%
This company
38.2%
Market median
-212% vs market
20082024
Return on equity
-249209900.0%
This company
18.4%
Market median
-1354401730% vs market
20082024
Net profit margin
-249209900.0%
This company
8.1%
Market median
-3076665532% vs market
20082024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20082024
Debt / equity
3.34×
This company
0.62×
Market median
-439% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JI Deputy Member | Deputy Member | 2001 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2025 | — | — | |
| Chairman | 2001 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Industri Engasjement As | Company | 91.0% | 91.0% | 2024 |
| Individual | 5.0% | 5.0% | 2024 | |
Bakke Consulting As | Company | 4.0% | 4.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIO-INFORMATION TECHNOLOGY AS (this company)
Terra Control AsBoard members of BIO-INFORMATION TECHNOLOGY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Inge Moen | Deputy Member | 0 companies |
| Kjell Hans Bakke | Chairman | 0 companies |
| Per Jon Moen | Chairman | 0 companies |
| Simon Sigurdsson | Board of Directors | 0 companies |